Now, a team led by University of Pennsylvania School of Veterinary Medicine researchers shows that the immune system indeed recognizes the latent stage of the parasite Toxoplasma gondii ...

BDC-3042 is a proprietary agonist antibody that targets dectin-2, an immune-activating receptor expressed by tumor-associated macrophages (TAMs). This single-agent, dose-escalation Phase 1 clinical ...

Clinical data supporting mechanism of action reinforce potential as a novel cancer treatmentBRISBANE, Calif., March 25, 2025 ...

INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's ...

With the beginning of another year, it seems appropriate to go back to the beginning of time to explore the evolutionary roots of our immune system. Insights gained from an evolutionary ...

Whenever the immune system fights a pathogen, it has a memory of that experience, whether it's with an invader or a vaccine that mimics an infection, for example. Scientists have now developed a way ...

Details for the poster presentation: Title: TACTI-004: a double-blinded, randomized phase 3 trial in patients with advanced/metasttic non-small cell cancer receiving eftilagimod alfa (MHC class II ...